BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28

• Business

  Jazz Pharmaceuticals Announces Full Year And Fourth Quarter 2017 Financial Results

  Jazz Pharmaceuticals plc today announced financial results for the full year and the fourth quarter of 2017 and provided financial guidance for 2018.

  February 27, 2018

   · 

  49 min read
• Business

  Inogen Announces Fourth Quarter and Full Year 2017 Financial Results and Updates 2018 Guidance

  Inogen, Inc. reported financial results for the three-month and twelve-month periods ended December 31, 2017.

  February 27, 2018

   · 

  9 min read
• Business

  DexCom Reports Record Fourth Quarter and Fiscal Year 2017 Financial Results

  DexCom, Inc. reported its financial results as of and for the quarter and fiscal year ended December 31, 2017.

  February 27, 2018

   · 

  4 min read
• Pharm Country

  Celgene Provides Regulatory Update on Ozanimod for the Treatment of Relapsing Multiple Sclerosis

  Celgene Corporation has received a Refusal to File letter from the United States Food and Drug Administration regarding its New Drug Application for ozanimod in development for the treatment of patients with relapsing forms of multiple sclerosis.

  February 27, 2018

   · 

  3 min read
• Business

  Elekta Collaborates With Leading New York Cancer Center to Continue Development of Clinical Protocols for MR-linac Technology

  Elekta has entered into a research agreement with Memorial Sloan Kettering Cancer Center to investigate new treatment standards, imaging protocols, and treatment planning methodologies across various cancer indications.

  February 27, 2018

   · 

  3 min read
• Business

  Clinigen Group Plc: Good H1 Performance with Adjusted EPS up 13%

  Clinigen Group plc published its half year results for the six months ended 31 December 2017.

  February 27, 2018

   · 

  4 min read
• Pharm Country

  Vitamin Science announces Dr. Krawitz Dry Eye Support: Based on United States Patent for Relief of Dry Eye Symptoms

  Launch of a ground-breaking dry eye nutritional formula: Dr. Krawitz Dry Eye Support, completes a triad of Dr. Krawitz premium quality professional ocular supplements favored by doctors and patients.

  February 27, 2018

   · 

  2 min read
• BioMidwest

  Brewer Introduces Two New Saddle Stools to Help Keep Dentists and Hygienists More Comfortable and Productive

  The new stools feature 360° Dynamic Motion technology allowing freedom of movement that engages core muscles and helps to strengthen back muscles over time to reduce pain and fatigue.

  February 27, 2018

   · 

  1 min read
• Deals

  Revint Solutions Announces Acquisition of Naveos

  Acquisition expands suite of revenue integrity solutions for healthcare providers and adds market-leading capabilities in government reimbursement

  February 27, 2018

   · 

  4 min read
• Business

  Nordic Nanovector ASA - Results for the Fourth Quarter and Full Year 2017: Solid Performance Through 2017, Moving Forward With Pivotal Trial

  Nordic Nanovector made significant progress during 2017, continuing the strong positive momentum started in 2016.

  February 27, 2018

   · 

  9 min read